Consolidation ALK Tyrosine Kinase Inhibitors versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK+ Non-Small Cell Lung Cancer

Waggoner T, Garcia S, Chakravarty T, Makar M, Latib A, Kipperman RM, Zahr F, Hanson I, Sinha AK, Sharma RP, Depta JP, Castellanos JA, Kodali[...]

Min JH, Chen PJ, Qureshi TA, Javed S, Xie Y, Azab L, Wang L, Kim HS, Li D, Yang JD. Prediction of Immunotherapy Response in[...]

Huang LT, Zhang X, Li X, Malagi A, Huang Y, Guan X, Ho H, Kwan A, Wei J, Bi X, Christodoulou AG, Li D, Han[...]